Company Overview

Update
Founded:
2011
Founders:
Christopher Grant Ward, Sean Ward
Headquarters:
London
Funding:
$4.9M
Categories:
Biotechnology
Description:
Synthace produces bio-based chemical products through the application of synthetic biology.

Detailed Description

Update

Synthace is the UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace harnesses the ability of micro-organisms to produce complex, high-value chemical and biological products from sustainable and renewable feedstocks. In addition to equity funding, the company has received a £500,000 Technology Strategy Board award entitled ‘Rapid Engineering of Cellular Factories’, in collaboration with University College London and University of Manchester. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is initially focused towards applications in the production of specialty chemicals.

Current Team (4)

Update

Funding Rounds (3) - $4.9M

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Office

    9 Woburn Walk

    London, WC1H 0JE

    GBR

Images (1)

Update
  • 1aff29d3627e1831ed46806f5c0ea391

Portions of this content provided by: